We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.85B
AUM Growth
-$202M
Cap. Flow
-$288M
Cap. Flow %
-15.59%
Top 10 Hldgs %
31.04%
Holding
450
New
28
Increased
86
Reduced
211
Closed
50

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$59.2M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$55.1M
3
BAC icon
Bank of America
BAC
+$21.4M
4
ABT icon
Abbott
ABT
+$16.5M
5
GL icon
Globe Life
GL
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 19.46%
2 Energy 16.48%
3 Industrials 10.8%
4 Financials 10.7%
5 Technology 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
151
Supernus Pharmaceuticals
SUPN
$2.73B
$1.68M 0.09%
70,688
-104,200
-60% -$2.53M
DEO icon
152
Diageo
DEO
$47.3B
$1.67M 0.09%
9,910
-308
-3% -$50.1K
ISSC icon
153
Innovative Solutions & Support
ISSC
$345M
$1.62M 0.09%
278,129
-23,038
-8% -$111K
CDXS icon
154
Codexis
CDXS
$141M
$1.61M 0.09%
100,432
-4,100
-4% -$60.7K
META icon
155
Meta Platforms (Facebook)
META
$1.51T
$1.59M 0.09%
7,767
-145
-2% -$28.1K
TXN icon
156
Texas Instruments
TXN
$255B
$1.57M 0.09%
12,258
-500
-4% -$61.7K
MNR
157
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.53M 0.08%
105,607
+52
+0% +$768
WY icon
158
Weyerhaeuser
WY
$17.2B
$1.53M 0.08%
50,587
+50
+0.1% +$1.45K
PM icon
159
Philip Morris
PM
$305B
$1.53M 0.08%
17,939
-1,820
-9% -$150K
XLV icon
160
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$1.5M 0.08%
14,708
+238
+2% +$22.9K
CAT icon
161
Caterpillar
CAT
$402B
$1.49M 0.08%
10,113
+413
+4% +$57.6K
ELAN icon
162
Elanco Animal Health
ELAN
$12.7B
$1.47M 0.08%
49,783
-1,760
-3% -$47.8K
WELL icon
163
Welltower
WELL
$175B
$1.47M 0.08%
17,916
-1
-0% -$86
DOW icon
164
Dow Inc
DOW
$20.8B
$1.44M 0.08%
26,262
-7,915
-23% -$409K
CEMI
165
DELISTED
Chembio diagnostics, Inc.
CEMI
$1.41M 0.08%
309,244
+6,000
+2% +$29.2K
GDX icon
166
VanEck Gold Miners ETF
GDX
$23.2B
$1.37M 0.07%
46,915
+19,075
+69% +$521K
VRSK icon
167
Verisk Analytics
VRSK
$27.1B
$1.36M 0.07%
9,120
-130
-1% -$19.3K
GE icon
168
GE Aerospace
GE
$375B
$1.35M 0.07%
24,340
-195
-0.8% -$10.1K
AGN
169
DELISTED
Allergan plc
AGN
$1.35M 0.07%
7,059
-100
-1% -$18K
UTG icon
170
Reaves Utility Income Fund
UTG
$3.64B
$1.35M 0.07%
36,349
-1,550
-4% -$56.8K
NEPH icon
171
Nephros
NEPH
$37.2M
$1.34M 0.07%
134,539
+68,750
+105% +$612K
RPM icon
172
RPM International
RPM
$13.8B
$1.33M 0.07%
17,340
NVO
173
Novo Nordisk
NVO
$220B
$1.29M 0.07%
44,636
+7,130
+19% +$197K
DTE icon
174
DTE Energy
DTE
$30.6B
$1.27M 0.07%
11,528
CP icon
175
Canadian Pacific Kansas City
CP
$81.1B
$1.26M 0.07%
24,785
+75
+0.3% +$3.52K

Similar funds

Ingalls & Snyder LLC's Q4 2019 Portfolio in Review

As of Q4 2019, Ingalls & Snyder LLC held 450 positions worth $1.85B, down 9.9% from $2.05B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ingalls & Snyder LLC withdrew a net $288M in Q4 2019, closing 50 positions and reducing 211 holdings. Its most notable exit was Apple, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Energy and Industrials.

Against the trend, Ingalls & Snyder LLC opened a new position in ROSETTA STONE INC worth $539K.

  • Ingalls & Snyder LLC's largest Q4 2019 buy was ROSETTA STONE INC: 29,710 shares worth $539K.
  • Ingalls & Snyder LLC added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.86M increase.
  • Ingalls & Snyder LLC's biggest Q4 2019 reduction was Corcept Therapeutics, cutting an estimated $9.71M.
  • Ingalls & Snyder LLC fully exited Apple in Q4 2019, selling an estimated $59.2M.
  • Ingalls & Snyder LLC's ten largest holdings make up 31% of its $1.85B portfolio in Q4 2019.
  • Ingalls & Snyder LLC opened 28 new positions and closed 50 in Q4 2019.
  • Ingalls & Snyder LLC's portfolio value fell 9.9% quarter-over-quarter to $1.85B.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2019, filed 15 Jan 2020.